Literature DB >> 16783774

Expression of DNA mismatch repair gene MSH2 in cytological material from lung cancer patients.

George Kanellis1, Ioulia Chatzistamou, Helen Koutselini, Ekaterini Politi, Athanasios Gouliamos, Lambros Vlahos, Antonis Koutselinis.   

Abstract

Mismatch repair genes encode for proteins responsible for the correction of bases incorrectly paired in the DNA. Loss of DNA mismatch repair activity has been associated with various cancers including tumors of the lung. In the present study, we have analyzed by immunocytochemistry the expression of MSH2 DNA repair gene in cytological material obtained by fine needle aspiration from a panel of 42 primary lung cancer patients. Specimens included 13 adenocarcinomas, 11 small cell carcinomas and 18 squamous cell carcinomas. Loss of expression or low expression was detected in 6 out of 13 (46%) adenocarcinomas and in 7 out of 18 (39%) of squamous cell carcinomas, although all 11 small cell carcinomas expressed MSH2. Our results suggest that loss of MSH2 expression is frequent in nonsmall cell carcinomas of the lung (P < 0.01, chi2 test). Evaluation of MSH2 expression can be applied for the screening of cytological material from fine needle aspirations from the lung. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16783774     DOI: 10.1002/dc.20473

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  5 in total

1.  miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in lung cancer.

Authors:  Zhiwei Zhong; Zhuo Dong; Lihua Yang; Zhaohui Gong
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-18       Impact factor: 4.553

2.  Oxidative Stress and Deregulated DNA Damage Response Network in Lung Cancer Patients.

Authors:  Dimitra T Stefanou; Marousa Kouvela; Dimitris Stellas; Konstantinos Voutetakis; Olga Papadodima; Konstantinos Syrigos; Vassilis L Souliotis
Journal:  Biomedicines       Date:  2022-05-26

3.  Two co-existing germline mutations P53 V157D and PMS2 R20Q promote tumorigenesis in a familial cancer syndrome.

Authors:  Zuoyun Wang; Yihua Sun; Bin Gao; Yi Lu; Rong Fang; Yijun Gao; Tian Xiao; Xin-Yuan Liu; William Pao; Yun Zhao; Haiquan Chen; Hongbin Ji
Journal:  Cancer Lett       Date:  2013-08-24       Impact factor: 8.679

Review 4.  The potential of exploiting DNA-repair defects for optimizing lung cancer treatment.

Authors:  Sophie Postel-Vinay; Elsa Vanhecke; Ken A Olaussen; Christopher J Lord; Alan Ashworth; Jean-Charles Soria
Journal:  Nat Rev Clin Oncol       Date:  2012-02-14       Impact factor: 66.675

5.  Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancers.

Authors:  Astrid Rohrbeck; Judith Neukirchen; Michael Rosskopf; Guillermo G Pardillos; Helene Geddert; Andreas Schwalen; Helmut E Gabbert; Arndt von Haeseler; Gerald Pitschke; Matthias Schott; Ralf Kronenwett; Rainer Haas; Ulrich-Peter Rohr
Journal:  J Transl Med       Date:  2008-11-07       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.